Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(16):1192; doi:10.1093/jnci/95.16.1192
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

NCI, FDA to Collaborate on Speeding Up Drug Discovery

Katherine Arnold

The first 10% of the full text of this article appears below.

The National Cancer Institute and the U.S. Food and Drug Administration have made an interagency agreement to share resources and personnel with hopes of speeding the drug development and approval process.

The agreement was formally announced at this year’s annual meeting of the American Society of Clinical Oncology in a staged talk show-like discussion among FDA Commissioner . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?